
1. nature. 1997 feb 13;385(6617):645-9.

ccr3 ccr5 co-receptors hiv-1 infection microglia.

he j(1), chen y, farzan m, choe h, ohagen a, gartner s, busciglio j, yang x,
hofmann w, newman w, mackay cr, sodroski j, gabuzda d.

author information: 
(1)division human retrovirology, dana-farber cancer institute, boston,
massachusetts 02115, usa.

several members chemokine receptor family used together cd4 for
hiv-1 entry target cells. cell line-tropic (t-tropic) hiv-1 viruses use
the chemokine receptor cxcr4 co-receptor, whereas macrophage-tropic
(m-tropic) primary viruses use ccr5 (refs 2-6). individuals defective ccr5
alleles exhibit resistance hiv-1 infection, suggesting ccr5 an
important role vivo hiv-1 replication. subset primary viruses use 
ccr3 well ccr5 co-receptor, vivo contribution ccr3 to
hiv-1 infection pathogenesis unknown. hiv-1 infects central nervous
system (cns) causes dementia associated aids. report that
the major target cells hiv-1 infection cns, microglia, express
both ccr3 ccr5. ccr3 ligand, eotaxin, anti-ccr3 antibody inhibited
hiv-1 infection microglia, mip-1beta, ccr5 ligand. our
results suggest ccr3 ccr5 promote efficient infection cns by
hiv-1.

doi: 10.1038/385645a0 
pmid: 9024664  [indexed medline]

